A Swiss Biotechnical Company dedicated to drug discovery
Invenesis provides a unique panel of phenotypic and electrophysiological assays, which can be used in combination to perform high or low throughput screening. These assays can also be used to identify the mode of action and potential side effects of a given compound. With this flexibility, Invenesis is able to efficiently identify hits, profile hit compounds, and perform lead optimization cycles, allowing customers to generate Intellectual Property (IP) effectively.
A Swiss Biotechnical Company dedicated to drug discovery
Invenesis provides a unique panel of phenotypic and electrophysiological assays, which can be used in combination to perform high or low throughput screening. These assays can also be used to identify the mode of action and potential side effects of a given compound. With this flexibility, INVENesis is able to efficiently identify hits, profile hit compounds, and perform lead optimization cycles, allowing customers to generate Intellectual Property (IP) effectively.
Who we Are
Invenesis is a Swiss biotechnology company based in Neuchâtel, which specializes in providing R&D services for drug discovery to industrial partners in the Animal Health, Plant Protection (Crop) and Pharmaceutical fields, as well as academia. Founded in March 2017 by experienced scientists with over 12 years of experience in drug discovery, Invenesis has a track record of developing successful candidates and drugs that are now on the market.
Where we Are
Since September 2020, the company has been re-located in Saint-Blaise (NE) and now welcomes around ten employees, a subsidiary in France, and an international clientele consisting of both startups and multinationals, as well as academic institutions.
The company headquarters features brand new state-of-the-art laboratories with a total area of 370 sq. meters (including 100 sq. meters of BSL2 labs).
What we Do
As an agile company that is part of an ecosystem of companies focused on developing drugs, pheromones, bio-controls, and biologics for applications in parasitology, agriculture, and human medicine, Invenesis operates on a fee-for-service business model. This allows for lower costs of entry for technologies and expertise, making it an ideal partner for companies looking to share resources and collaborate in the development of new drugs.
Meet Our Team
Our team consists of a panel of specialists in the field of Animal Health, electrophysiology and molecular biology. We are proud to bring together these talents to serve our clients.
Testimonial
What the Industry Says :
“Invenesis has in-depth and unique expertise in testing synthetic small molecules, natural products and plant extracts against parasites of human and veterinary importance, as well as in elucidating modes of action by electrophysiology on specific parasite receptors. Our collaborations with Invenesis have been very insightful to accelerate our innovation programs.”
Our Values
Invenesis combines “Innovation” and “Genesis” to signify the birth of something new and innovative. Biotechnology advancements are at the core of our DNA with a focus on creating cutting-edge assays and technologies.
